Catch us at an upcoming conference or tradeshow – or sign up for one of our own upcoming events and Benchtalk forums.
Molecular Biology Webinar
July 12, 2019Online
Join Benchling as we discuss common molecular biology workflows and the pain points faced by many of our clients. We will showcase how Benchling’s Bulk DNA Assembly tool and unified R&D platform help solve these problems, and will end with 15 minutes of Q&A.
Molecular biology research is now more complex than ever, while research workflows are more diverse and require more steps. The teams carrying out the research are specialized and have more needs for collaboration and productivity. To handle this complexity, research teams need automated, high-throughput tools for sequence design and workflow management.
Please register to join us for this live webinar by clicking on the link.
Join Benchling for our annual San Diego happy hour where you can meet the local community of life sciences R&D and technology professionals. You'll have the opportunity to hear from industry leaders about top challenges, and their best practices to organize, optimize, and measure R&D — all while enjoying delicious appetizers, drinks, and the chance to network with your peers.
Join Benchling for a happy hour where you can meet the Seattle community of life sciences R&D and technology professionals. Hear from industry leaders about top challenges, and their best practices to organize, optimize, and measure R&D. You’ll also have the chance to enjoy delicious appetizers and drinks and network with your peers.
The 17th Annual Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, will convene over 1,300 drug discovery professionals in Boston, MA, on September 16-19, 2019. This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. They're dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.